Semaglutide <scp>2.4 mg</scp> Cardiometabolic Long‐Term Effects in Patients With Obesity or Overweight in a Real‐World Setting: A Retrospective Cohort Study in the United States ( <scp>SMILE</scp> )

Aleksandrina Ruseva, Wojciech Michalak, Matthew Bassan, Ella Xiaoyan Du, Anthony Fabricatore, Bríain Ó Hartaigh, Theo Man, Ramya Ramasubramanian, Pangsibo Shen, Jinlin Song, Zhenxiang Zhao, Francisco Lopez‐Jimenez

Open source

DOI: 10.1111/dom.70746
Published: 2026-04-27
Container: Diabetes, Obesity and Metabolism
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.70746,
  title = {Semaglutide
                    <scp>2.4 mg</scp>
                    Cardiometabolic Long‐Term Effects in Patients With Obesity or Overweight in a Real‐World Setting: A Retrospective Cohort Study in the United States (
                    <scp>SMILE</scp>
                    )},
  author = {Aleksandrina Ruseva and Wojciech Michalak and Matthew Bassan and Ella Xiaoyan Du and Anthony Fabricatore and Bríain Ó Hartaigh and Theo Man and Ramya Ramasubramanian and Pangsibo Shen and Jinlin Song and Zhenxiang Zhao and Francisco Lopez‐Jimenez},
  year = {2026},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.70746},
  url = {https://doi.org/10.1111/dom.70746}
}

RIS

TY  - JOUR
TI  - Semaglutide
                    <scp>2.4 mg</scp>
                    Cardiometabolic Long‐Term Effects in Patients With Obesity or Overweight in a Real‐World Setting: A Retrospective Cohort Study in the United States (
                    <scp>SMILE</scp>
                    )
AU  - Aleksandrina Ruseva
AU  - Wojciech Michalak
AU  - Matthew Bassan
AU  - Ella Xiaoyan Du
AU  - Anthony Fabricatore
AU  - Bríain Ó Hartaigh
AU  - Theo Man
AU  - Ramya Ramasubramanian
AU  - Pangsibo Shen
AU  - Jinlin Song
AU  - Zhenxiang Zhao
AU  - Francisco Lopez‐Jimenez
PY  - 2026
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.70746
UR  - https://doi.org/10.1111/dom.70746
ER  -

APA

Ruseva, A., Michalak, W., Bassan, M., Du, E. X., Fabricatore, A., Hartaigh, B. Ó., Man, T., Ramasubramanian, R., Shen, P., Song, J., Zhao, Z., & Lopez‐Jimenez, F. (2026). Semaglutide <scp>2.4 mg</scp> Cardiometabolic Long‐Term Effects in Patients With Obesity or Overweight in a Real‐World Setting: A Retrospective Cohort Study in the United States ( <scp>SMILE</scp> ). Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70746

Source records

crossref · retrieved 2026-09-26T19:03:47.231Z